Skip to main content

Table 2 The percentages of CD69+ CD19+ cells in myocardium, spleen, and blood in AMI and control mice

From: Are activated B cells involved in the process of myocardial fibrosis after acute myocardial infarction? An in vivo experiment

Group n CD19+ CD69+ (%)
Myocardium Spleen Blood
AMI 3d 8 10.62 ± 1.62*# 6.05 ± 0.73*# 5.32 ± 0.73*#
Sham 3d 6 3.72 ± 0.51 3.62 ± 0.36 2.29 ± 0.43
AMI 5d 8 22.71 ± 3.43* 12.40 ± 2.07* 6.82 ± 0.77*
Sham 5d 6 3.75 ± 0.29 3.80 ± 0.40 2.76 ± 0.39
AMI 1W 8 7.62 ± 1.74*# 4.02 ± 0.58*# 3.60 ± 0.73#
Sham 1W 6 3.53 ± 0.65 3.71 ± 0.56 2.84 ± 0.55
AMI 2W 8 4.45 ± 0.75# 4.13 ± 0.82# 3.10 ± 0.58#
Sham 2W 6 3.40 ± 0.44 3.58 ± 0.59 2.58 ± 0.67
  1. *P < 0.05, the activated B cell ratio of AMI group was compared with the corresponding subgroups of the Sham group
  2. #P < 0.05, the activated B cell ratio of other subgroups of the AMI group was compared with AMI 5 days subgroups. Data are represented by mean ± standard deviation